{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:27:10Z","timestamp":1770492430802,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:00:00Z","timestamp":1613865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:00:00Z","timestamp":1613865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2020JJ5877"],"award-info":[{"award-number":["2020JJ5877"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific research project of Hunan Health Commission","award":["20201453"],"award-info":[{"award-number":["20201453"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00284-021-02386-z","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T10:02:25Z","timestamp":1613901745000},"page":"1159-1167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of Eltrombopag as a Repurposing Drug Against Staphylococcus epidermidis and its Biofilms"],"prefix":"10.1007","volume":"78","author":[{"given":"Juan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canhui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,21]]},"reference":[{"key":"2386_CR1","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2217\/fmb.15.98","volume":"10","author":"S Kleinschmidt","year":"2015","unstructured":"Kleinschmidt S, Huygens F, Faoagali J et al (2015) Staphylococcus epidermidis as a cause of bacteremia. Future Microb 10:1859\u20131879. https:\/\/doi.org\/10.2217\/fmb.15.98","journal-title":"Future Microb"},{"key":"2386_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fmicb.2018.00359","volume":"16","author":"AL Byrd","year":"2018","unstructured":"Byrd AL, Belkaid Y, Segre JA (2018) The human skin microbiome. Nat Rev Microbiol 16:143\u2013155. https:\/\/doi.org\/10.3389\/fmicb.2018.00359","journal-title":"Nat Rev Microbiol"},{"key":"2386_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature09074","volume":"465","author":"T Iwase","year":"2010","unstructured":"Iwase T, Uehara Y, Shinji H et al (2010) Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465:346\u2013349. https:\/\/doi.org\/10.1038\/nature09074","journal-title":"Nature"},{"key":"2386_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fcimb.2015.00014","volume":"5","author":"H B\u00fcttner","year":"2015","unstructured":"B\u00fcttner H, Mack D, Rohde H et al (2015) Structural basis of Staphylococcus epidermidis biofilm formation: mechanisms and molecular interactions. Front Cell Infect Microbiol 5:14. https:\/\/doi.org\/10.3389\/fcimb.2015.00014","journal-title":"Front Cell Infect Microbiol"},{"key":"2386_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4248\/IJOS11026","volume":"3","author":"N H\u00f8iby","year":"2011","unstructured":"H\u00f8iby N, Ciofu O, Johansen HK et al (2011) The clinical impact of bacterial biofilms. Int J Oral Sci 3:55\u201365. https:\/\/doi.org\/10.4248\/IJOS11026","journal-title":"Int J Oral Sci"},{"key":"2386_CR6","doi-asserted-by":"publisher","first-page":"e1006012","DOI":"10.1371\/journal.ppat.1006012","volume":"12","author":"EM Waters","year":"2016","unstructured":"Waters EM, Rowe SE, O\u2019Gara JP et al (2016) Convergence of Staphylococcus aureus persister and biofilm research: can biofilms be defined as communities of adherent persister cells? PLoS Pathog 12:e1006012. https:\/\/doi.org\/10.1371\/journal.ppat.1006012","journal-title":"PLoS Pathog"},{"key":"2386_CR7","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.2174\/0929867325666180706101404","volume":"26","author":"AK Konreddy","year":"2019","unstructured":"Konreddy AK, Rani GU, Lee K et al (2019) Recent drug-repurposing-driven advances in the discovery of novel antibiotics. Curr Med Chem 26:5363\u20135388. https:\/\/doi.org\/10.2174\/0929867325666180706101404","journal-title":"Curr Med Chem"},{"key":"2386_CR8","doi-asserted-by":"publisher","first-page":"16529","DOI":"10.1073\/pnas.1904700116","volume":"116","author":"W Kim","year":"2019","unstructured":"Kim W, Zou G, Hari TPA et al (2019) A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus. PNAS 116:16529\u201316534. https:\/\/doi.org\/10.1073\/pnas.1904700116","journal-title":"PNAS"},{"key":"2386_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jam.14443","volume":"128","author":"P She","year":"2020","unstructured":"She P, Liu Y, Wang Y et al (2020) Antibiofilm efficacy of the gold compound auranofin on dual species biofilms of Staphylococcus aureus and Candida sp. J Appl Microb 128:88\u2013101. https:\/\/doi.org\/10.1111\/jam.14443","journal-title":"J Appl Microb"},{"key":"2386_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","volume":"180","author":"JM Stokes","year":"2020","unstructured":"Stokes JM, Yang K, Swanson K et al (2020) A deep learning approach to antibiotic discovery. Cell 180:688\u2013702. https:\/\/doi.org\/10.1016\/j.cell.2020.01.021","journal-title":"Cell"},{"key":"2386_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/2040620717693573","volume":"8","author":"H Gill","year":"2017","unstructured":"Gill H, Wong RSM, Kwong YL (2017) From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag. Ther Adv Hematol 8:159\u2013174. https:\/\/doi.org\/10.1177\/2040620717693573","journal-title":"Ther Adv Hematol"},{"key":"2386_CR12","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41409-019-0435-2","volume":"54","author":"H Fu","year":"2019","unstructured":"Fu H, Zhang X, Han T, Mo X et al (2019) Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation. Bone Marrow Transplant 54:1310\u20131318. https:\/\/doi.org\/10.1038\/s41409-019-0435-2","journal-title":"Bone Marrow Transplant"},{"key":"2386_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/cells9010031","volume":"9","author":"JU Vogel","year":"2019","unstructured":"Vogel JU, Schmidt S, Schmidt D et al (2019) The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation. Cells 9:31. https:\/\/doi.org\/10.3390\/cells9010031","journal-title":"Cells"},{"key":"2386_CR14","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1182\/blood-2007-12-126854","volume":"112","author":"PN Paradkar","year":"2008","unstructured":"Paradkar PN, De Domenico I, Durchfort N et al (2008) Iron depletion limits intracellular bacterial growth in macrophages. Blood 112:866\u2013874. https:\/\/doi.org\/10.1182\/blood-2007-12-126854","journal-title":"Blood"},{"key":"2386_CR15","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s41564-018-0230-7","volume":"3","author":"JYH Lee","year":"2018","unstructured":"Lee JYH, Monk IR, Gon\u00e7alves da Silva A et al (2018) Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis. Nat Microbiol 3:1175\u20131185. https:\/\/doi.org\/10.1038\/s41564-018-0230-7","journal-title":"Nat Microbiol"},{"key":"2386_CR16","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-ninth edition. CLSI document M100","author":"Clinical and Laboratory Standards Institute [CLSI]","year":"2019","unstructured":"Clinical and Laboratory Standards Institute [CLSI] (2019) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-ninth edition. CLSI document M100. Clinical and Laboratory Standards Institute, Wayne, PA"},{"key":"2386_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.diagmicrobio.2018.11.005","volume":"93","author":"D Knaack","year":"2019","unstructured":"Knaack D, Idelevich EA, Schleimer N et al (2019) Bactericidal activity of bacteriophage endolysin HY-133 against Staphylococcus aureus in comparison to other antibiotics as determined by minimum bactericidal concentrations and time\u2013kill analysis. Comparative Study 93:362\u2013368. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.11.005","journal-title":"Comparative Study"},{"key":"2386_CR18","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.3389\/fmicb.2019.02453","volume":"10","author":"P She","year":"2019","unstructured":"She P, Zhou L, Li S et al (2019) Synergistic microbicidal effect of auranofin and antibiotics against planktonic and biofilm-encased S. aureus and E. faecalis. Front Microb 10:2453. https:\/\/doi.org\/10.3389\/fmicb.2019.02453","journal-title":"Front Microb"},{"issue":"2","key":"2386_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5578\/mb.7104","volume":"48","author":"H Turk Dagi","year":"2014","unstructured":"Turk Dagi H, Kus H, Arslan U, Tuncer I (2014) In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates. Mikrobiyol Bul 48(2):311\u2013315. https:\/\/doi.org\/10.5578\/mb.7104","journal-title":"Mikrobiyol Bul"},{"key":"2386_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drup.2018.03.002","volume":"38","author":"V Defraine","year":"2018","unstructured":"Defraine V, Fauvart M, Michiels J (2018) Fighting bacterial persistence: current and emerging anti-persister strategies and therapeutics. Drug Resist Update 38:12\u201326. https:\/\/doi.org\/10.1016\/j.drup.2018.03.002","journal-title":"Drug Resist Update"},{"key":"2386_CR21","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.leukres.2010.02.005","volume":"34","author":"CL Erickson-Miller","year":"2010","unstructured":"Erickson-Miller CL, Kirchner J, Aivado M et al (2010) A reduced proliferation of non-megakaryocytic acute myelogenous leukemia and other leukemia and lymphoma cell lines in response to eltrombopag. Leuk Res 34:1224\u20131231. https:\/\/doi.org\/10.1016\/j.leukres.2010.02.005","journal-title":"Leuk Res"},{"key":"2386_CR22","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3892\/ijo.2015.3180","volume":"47","author":"T Kurokawa","year":"2015","unstructured":"Kurokawa T, Murata S, Zheng YW et al (2015) The Eltrombopag antitumor effect on hepatocellular carcinoma. Inter J Oncol 47:1696\u20131702. https:\/\/doi.org\/10.3892\/ijo.2015.3180","journal-title":"Inter J Oncol"},{"key":"2386_CR23","doi-asserted-by":"publisher","first-page":"E385","DOI":"10.3390\/v11040385","volume":"11","author":"S Yuan","year":"2019","unstructured":"Yuan S, Chan JF, Ye ZW et al (2019) Screening of an FDA-approved drug library with a two-tier system identifies an entry inhibitor of severe fever with thrombocytopenia syndrome virus. Viruses 11:E385. https:\/\/doi.org\/10.3390\/v11040385","journal-title":"Viruses"},{"key":"2386_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1574-6968.2007.00688.x","volume":"270","author":"JP O'Gara","year":"2007","unstructured":"O\u2019Gara JP (2007) Ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microb Lett 270:179\u2013188","journal-title":"FEMS Microb Lett"},{"key":"2386_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2217\/fmb.14.31","volume":"9","author":"R Singh","year":"2014","unstructured":"Singh R, Ray P (2014) Quorum sensing-mediated regulation of staphylococcal virulence and antibiotic resistance. Future Microb 9:669\u2013681. https:\/\/doi.org\/10.2217\/fmb.14.31","journal-title":"Future Microb"},{"key":"2386_CR26","doi-asserted-by":"publisher","first-page":"7017","DOI":"10.1021\/la401322k","volume":"29","author":"EJ Stewart","year":"2013","unstructured":"Stewart EJ, Satorius AE, Younger JG et al (2013) Role of environmental and antibiotic stress on Staphylococcus epidermidis biofilm microstructure. Langmuir 29:7017\u20137024. https:\/\/doi.org\/10.1021\/la401322k","journal-title":"Langmuir"},{"key":"2386_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fcimb.2019.00128","volume":"9","author":"MS Zharkova","year":"2019","unstructured":"Zharkova MS, Orlov DS, Golubeva OY et al (2019) Application of antimicrobial peptides of the innate immune system in combination with conventional antibiotics-a novel way to combat antibiotic resistance? Front Cell Infect Microbiol 9:128. https:\/\/doi.org\/10.3389\/fcimb.2019.00128","journal-title":"Front Cell Infect Microbiol"},{"key":"2386_CR28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.tim.2016.06.009","volume":"24","author":"GD Wright","year":"2016","unstructured":"Wright GD (2016) Antibiotic adjuvants: rescuing antibiotics from resistance. Trends Microbiol 24:862\u2013871. https:\/\/doi.org\/10.1016\/j.tim.2016.06.009","journal-title":"Trends Microbiol"},{"key":"2386_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ptr.6208","volume":"33","author":"F Farhadi","year":"2019","unstructured":"Farhadi F, Khameneh B, Iranshahi M et al (2019) Antibacterial activity of flavonoids and their structure\u2013activity relationship: an update review. Phytother Res 33:13\u201340. https:\/\/doi.org\/10.1002\/ptr.6208","journal-title":"Phytother Res"},{"key":"2386_CR30","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.tibs.2018.06.011","volume":"43","author":"N V\u00e1zquez-Laslop","year":"2018","unstructured":"V\u00e1zquez-Laslop N, Mankin AS (2018) How macrolide antibiotics work. Trends Biochem Sci 43:668\u2013684. https:\/\/doi.org\/10.1016\/j.tibs.2018.06.011","journal-title":"Trends Biochem Sci"},{"key":"2386_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ejim.2014.09.006","volume":"25","author":"G Moulis","year":"2014","unstructured":"Moulis G, Bagheri H, Sailler L et al (2014) Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009\u20132013 French PharmacoVigilance assessment. Euro J Inter Med 25:777\u2013780. https:\/\/doi.org\/10.1016\/j.ejim.2014.09.006","journal-title":"Euro J Inter Med"},{"key":"2386_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/10245332.2017.1422306","volume":"23","author":"YY Hwang","year":"2018","unstructured":"Hwang YY, Gill H, Chan TSY et al (2018) Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting. Hematology 23:399\u2013404","journal-title":"Hematology"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-021-02386-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00284-021-02386-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-021-02386-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T05:26:19Z","timestamp":1616736379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00284-021-02386-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,21]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2386"],"URL":"https:\/\/doi.org\/10.1007\/s00284-021-02386-z","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,21]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}